Arzoxifene is a selective estrogen receptor modulator (SERM) that was developed for the prevention and treatment of osteoporosis in postmenopausal women. It works by binding to estrogen receptors, mimicking estrogen's beneficial effects on bone while blocking potential negative effects on breast tissue.